Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Mason

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
New Scientist (1971)|July 16, 1987
Porton defends nerve-gas tests on humansIan Mason
The Journal of Small Animal Practice|November 24, 2004
Proposed changes to medicines legislationIan Mason
Veterinary Dermatology|October 14, 2021
Bacterial skin diseases and World CongressesIan Mason
Future Microbiology|September 27, 2018
ECCMID 2018 meeting report: the continuing clinical challenge of nontuberculous mycobacteria lung diseaseIan Mason
Trends in Endocrinology and Metabolism: TEM|August 1, 1993
The 3beta-hydroxysteroid dehydrogenase gene family of enzymesJ Ian Mason
Veterinary Dermatology|October 14, 2021
Goodbyes and hellosIan Mason, David Lloyd
The Journal of Small Animal Practice|March 26, 2005
Responding to the draft veterinary medicines regulationsIan Mason, Mike Jessop
The Journal of Steroid Biochemistry and Molecular Biology|January 18, 2015
Steroid promiscuity: Diversity of enzyme action. PrefaceRichard Lathe, Yuri Kotelevtsev, J Ian Mason
Endocrine Reviews|November 6, 2009
Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compoundsHayley M Scott, J Ian Mason, Richard M Sharpe
Endocrine Research|January 18, 2003
Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156YJames L Thomas, J Ian Mason, Stacey Brandt, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
New Scientist (1971)|July 16, 1987
Porton defends nerve-gas tests on humansIan Mason
The Journal of Small Animal Practice|November 24, 2004
Proposed changes to medicines legislationIan Mason
Veterinary Dermatology|October 14, 2021
Bacterial skin diseases and World CongressesIan Mason
Future Microbiology|September 27, 2018
ECCMID 2018 meeting report: the continuing clinical challenge of nontuberculous mycobacteria lung diseaseIan Mason
Trends in Endocrinology and Metabolism: TEM|August 1, 1993
The 3beta-hydroxysteroid dehydrogenase gene family of enzymesJ Ian Mason
Veterinary Dermatology|October 14, 2021
Goodbyes and hellosIan Mason, David Lloyd
The Journal of Small Animal Practice|March 26, 2005
Responding to the draft veterinary medicines regulationsIan Mason, Mike Jessop
The Journal of Steroid Biochemistry and Molecular Biology|January 18, 2015
Steroid promiscuity: Diversity of enzyme action. PrefaceRichard Lathe, Yuri Kotelevtsev, J Ian Mason
Endocrine Reviews|November 6, 2009
Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compoundsHayley M Scott, J Ian Mason, Richard M Sharpe
Endocrine Research|January 18, 2003
Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156YJames L Thomas, J Ian Mason, Stacey Brandt, et al.
Pageof 7